The Market and Potential for Molecular Point of Care (mPOC), 2021

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

WHERE IS MOLECULAR POINT OF CARE IN 2021?
MOLECULAR POINT OF CARE MARKET ANALYSIS

• • Table 1-1: Molecular Point of Care Market: 2019-2024
• Figure 1-1: mPOC Market by Disease Indication, 2019 (%; Respiratory, Other)
• Market Observations
• “Near-Patient” Molecular Systems Market
  • Table 1-2: Near Patient Molecular Systems Market: 2019-2024

CURRENT TRENDS
COVID-19 and mPOC
MOLECULAR POINT-OF-CARE DIAGNOSTICS DEFINED

• USAGE OF MOLECULAR POINT OF CARE
• LEADING MPOC PLATFORMS
  • Table 1-3: Market-Available Molecular POC Diagnostic Platforms
• TRENDS

SCOPE AND METHODOLOGY

CHAPTER TWO: MOLECULAR POINT-OF-CARE MARKET DEVELOPMENT AND TRENDS

• ADVANTAGES AND DISADVANTAGES OF MOLECULAR POINT OF CARE
  • Table 2-1: Disadvantages of Molecular Point of Care, by Setting
• JUSTIFICATION: THE SENSITIVITY/SPECIFICITY ARGUMENT
• NEW SYSTEMS AND MENU EXPANSION
  • Table 2-2: Recent Menu Expansions for Hospital and POC Molecular Platforms (Vendor, Platform, Menu Addition, Time to Results, CLIA-waiver, US/EU Availability)

INVESTMENT IN MPOC SYSTEMS

• CHINA AS A POC MARKET
• COMMON TESTS AND ANALYTES IN POC DIAGNOSTICS
• COMPONENT TECHNOLOGIES OF MOLECULAR POINT-OF-CARE DIAGNOSTICS
  • Microfluidics
  • qPCR
  • Microarrays
  • Isothermal Amplification
  • Test Automation
  • Primers and Probes
  • Detection
  • Next-Generation Sequencing
• MOLECULAR DIAGNOSTICS
  • Real-Time PCR (qPCR)
  • Isothermal Amplification Methods
  • Line Probe Assays
  • Next-Generation Sequencing
• APPLICATIONS AND POTENTIAL APPLICATIONS FOR MOLECULAR POINT-OF-CARE
  • COVID-19
  • Major Testing Applications for Molecular POC Diagnostics
  • Influenza
  • Hospital-Acquired Infections (HAIs)
  • Strep A
  • Respiratory Syncytial Virus (RSV)

EMERGING APPLICATIONS

• Other Respiratory Infections
• Group B Streptococcus
• STDs
• Tuberculosis
• Malaria
• Other Tropical and Neglected Diseases
• Cancer
• EUROPEAN DEVICE REGULATIONS NEARING

CHAPTER THREE: MARKET ANALYSIS

• MOLECULAR POINT OF CARE MARKET ANALYSIS
  • Table 3-1: Molecular Point of Care Market: 2019-2024
  • Table 3-2: Molecular Point of Care Market Share by Vendor, 2019 ($M, %)
  • Figure 3-1: Small-Footprint Molecular Point of Care Market, 2019 (%)
  • Table 3-3: Geographic Breakout of the Molecular Point of Care Market, 2019 (N. America, Europe, APAC, RoW)
  • Table 3-4: Segment Breakout of Molecular Point of Care Market, 2019 (Respiratory vs. Other)
  • Figure 3-2: Breakout of Molecular Point of Care Market, 2019 (%; Respiratory, Other)
• Respiratory Molecular Point of Care Segmentation
  • Table 3-5: Respiratory Segment Breakout, 2019 (Flu, RSV, Strep, Other)
  • Figure 3-3: Breakout of mPOC Respiratory, 2019 (%; Flu, Strep, RSV, Other)

“NEAR PATIENT MOLECULAR” MARKET

• • Table 3-6: Near Patient Molecular IVD Market: 2019-2024
• Market Share Near Patient
  • Table 3-7: Near Patient Molecular Market Share by Vendor, 2019

CHAPTER FOUR: COMPANY PROFILES

• ABBOTT LABORATORIES
• AIDIAN OY
• AKONNI BIOSYSTEMS
• BINX HEALTH, INC.
• BIOCARTIS NV
• BIOMÉRIEUX SA
• CEPHEID
  • Molecular Healthcare-Acquired Infection (HAI) Testing
  • Molecular Sexual Health and Women’s Health Testing
  • Molecular Critical Infectious Disease Testing
  • Molecular Oncology/Genetics Testing
• CREDO BIOSCIENCE
• CURETIS NV
• DIASORIN S.P.A
• GENMARK DIAGNOSTICS
• GREINER BIO-ONE GMBH
• MERIDIAN BIOSCIENCE, INC.
• MESA BIOTECH, INC.
• QIAGEN NV
• QUANTUMDX GROUP
• QUIDEL CORPORATION
• ROCHE
• SEKISUI DIAGNOSTICS LLC
• T2 BIOSYSTEMS